It is time to beat the beast once and for all.
I had RP and EBRT 2015 now PSA is climbing pretty quickly.
PSA Trend
05/17/2022: 15.2
04/14/2022:13.45
03/09/2022: 13.3
02/09/2022: 10.3
01/12/2022: 8.4
12/01/2021: 8.93
09/15/2021: 3.6
07/21/2021: 3.08
06/21/2021: 2.4
03/23/2021: 1.8
02/25/2021: 1.9
01/28/2021: 1.3
The reason i took so long to go on ADT is I tried alternative therapies like keto, HBOT, joe Tippens protocol, and Care Oncology Protocol. They don’t work as a mono therapy. At least for my cancer.
I also tried to get on two trials but didn’t qualify.
Presently M1a CSPC.
Mets to lymphs 3 locations in pelvic, one in chest and one in clavicle. Per latest PMSA scan in Nov 2021.
Im leaning towards the ADT (Orgovyx) Nuqueba, and docetaxel. Per the ARASENS trial.
My main concern is becoming resistant thus this regimen.
Other concerns are I don’t want to stay on ADT for years, and I would like to leave open option for BAT in the future.
Am i being to optimistic?
Can I even get this treatment per FDA?
How many docetaxel cycles and is there such a thing as low dose docetaxel?
Dr Saylor at MGH says time to start lupron
Consult at Dana Faber says lupron + abiraterone/prednisone
Dr Laccetti at MSK ADT+Abiraterone/prednisone
Thank you for your expert opinions